100 related articles for article (PubMed ID: 21864053)
1. Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats.
Kliem MA; Heeke BL; Franz CK; Radovitskiy I; Raore B; Barrow E; Snyder BR; Federici T; Kaye Spratt S; Boulis NM
Amyotroph Lateral Scler; 2011 Sep; 12(5):331-9. PubMed ID: 21864053
[TBL] [Abstract][Full Text] [Related]
2. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
[TBL] [Abstract][Full Text] [Related]
3. Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression.
Lu L; Zheng L; Viera L; Suswam E; Li Y; Li X; Estévez AG; King PH
J Neurosci; 2007 Jul; 27(30):7929-38. PubMed ID: 17652584
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice.
Wang Y; Mao XO; Xie L; Banwait S; Marti HH; Greenberg DA; Jin K
J Neurosci; 2007 Jan; 27(2):304-7. PubMed ID: 17215390
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy.
Price SA; Dent C; Duran-Jimenez B; Liang Y; Zhang L; Rebar EJ; Case CC; Gregory PD; Martin TJ; Spratt SK; Tomlinson DR
Diabetes; 2006 Jun; 55(6):1847-54. PubMed ID: 16731852
[TBL] [Abstract][Full Text] [Related]
6. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.
Storkebaum E; Lambrechts D; Dewerchin M; Moreno-Murciano MP; Appelmans S; Oh H; Van Damme P; Rutten B; Man WY; De Mol M; Wyns S; Manka D; Vermeulen K; Van Den Bosch L; Mertens N; Schmitz C; Robberecht W; Conway EM; Collen D; Moons L; Carmeliet P
Nat Neurosci; 2005 Jan; 8(1):85-92. PubMed ID: 15568021
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
[TBL] [Abstract][Full Text] [Related]
8. Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
Suzuki M; Svendsen CN
Methods Mol Biol; 2016; 1382():325-36. PubMed ID: 26611598
[TBL] [Abstract][Full Text] [Related]
9. Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia.
Dai Q; Huang J; Klitzman B; Dong C; Goldschmidt-Clermont PJ; March KL; Rokovich J; Johnstone B; Rebar EJ; Spratt SK; Case CC; Kontos CD; Annex BH
Circulation; 2004 Oct; 110(16):2467-75. PubMed ID: 15477407
[TBL] [Abstract][Full Text] [Related]
10. Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration.
Van Den Bosch L; Storkebaum E; Vleminckx V; Moons L; Vanopdenbosch L; Scheveneels W; Carmeliet P; Robberecht W
Neurobiol Dis; 2004 Oct; 17(1):21-8. PubMed ID: 15350962
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis.
Mòdol-Caballero G; García-Lareu B; Verdés S; Ariza L; Sánchez-Brualla I; Brocard F; Bosch A; Navarro X; Herrando-Grabulosa M
Neurotherapeutics; 2020 Jul; 17(3):1048-1060. PubMed ID: 31965551
[TBL] [Abstract][Full Text] [Related]
12. A Combination of Intrathecal and Intramuscular Application of Human Mesenchymal Stem Cells Partly Reduces the Activation of Necroptosis in the Spinal Cord of SOD1
Řehořová M; Vargová I; Forostyak S; Vacková I; Turnovcová K; Kupcová Skalníková H; Vodička P; Kubinová Š; Syková E; Jendelová P
Stem Cells Transl Med; 2019 Jun; 8(6):535-547. PubMed ID: 30802001
[TBL] [Abstract][Full Text] [Related]
13. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
14. The anti-inflammatory peptide stearyl-norleucine-VIP delays disease onset and extends survival in a rat model of inherited amyotrophic lateral sclerosis.
Goursaud S; Schäfer S; Dumont AO; Vergouts M; Gallo A; Desmet N; Deumens R; Hermans E
Exp Neurol; 2015 Jan; 263():91-101. PubMed ID: 25311268
[TBL] [Abstract][Full Text] [Related]
15. Treatment of traumatic brain injury using zinc-finger protein gene therapy targeting VEGF-A.
Siddiq I; Park E; Liu E; Spratt SK; Surosky R; Lee G; Ando D; Giedlin M; Hare GM; Fehlings MG; Baker AJ
J Neurotrauma; 2012 Nov; 29(17):2647-59. PubMed ID: 23016562
[TBL] [Abstract][Full Text] [Related]
16. An epigenetic analysis of SOD1 and VEGF in ALS.
Oates N; Pamphlett R
Amyotroph Lateral Scler; 2007 Apr; 8(2):83-6. PubMed ID: 17453634
[TBL] [Abstract][Full Text] [Related]
17. Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells.
López-González R; Kunckles P; Velasco I
Cell Transplant; 2009; 18(10):1171-81. PubMed ID: 19660174
[TBL] [Abstract][Full Text] [Related]
18. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
19. Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.
Mòdol-Caballero G; García-Lareu B; Herrando-Grabulosa M; Verdés S; López-Vales R; Pagès G; Chillón M; Navarro X; Bosch A
Neurotherapeutics; 2021 Apr; 18(2):1113-1126. PubMed ID: 33786805
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
